The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Show simple item record

dc.contributor.author Dizdarevic, S.
dc.contributor.author Tulchinsky, M.
dc.contributor.author McCready, V.R.
dc.contributor.author Mihailovic, J,
dc.contributor.author Vinjamuri, S.
dc.contributor.author Buscombe, J.R.
dc.contributor.author Lee, S.T.
dc.contributor.author Frangos, S.
dc.contributor.author Sathekge, Mike Machaba
dc.contributor.author Siraj, Q.
dc.contributor.author Choudhury, P.
dc.contributor.author Bom, H.
dc.contributor.author Franceschi, M.
dc.contributor.author Ugrinska, A.
dc.contributor.author Paez, D.
dc.contributor.author Hussain, R.
dc.contributor.author Mailman, J.
dc.contributor.author Luster, M.
dc.contributor.author Virgolini, I.
dc.date.accessioned 2020-09-10T06:09:31Z
dc.date.available 2020-09-10T06:09:31Z
dc.date.issued 2019-04
dc.description.abstract The World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) is a worldwide nonprofit organization, which is dedicated to educating medical professionals in the use of radionuclide therapies based on the theragnostic principles and to harmonizing appropriate evidence‑based practices worldwide. en_ZA
dc.description.department Nuclear Medicine en_ZA
dc.description.librarian pm2020 en_ZA
dc.description.uri http://www.wjnm.org en_ZA
dc.identifier.citation Dizdarevic, S., Tulchinsky, M., McCready, V.R. et al. 2019, 'The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma', World Journal of Nuclear Medicine, vol. 18, no. 2, pp. 123-126. en_ZA
dc.identifier.issn 1450-1147 (print)
dc.identifier.issn 1607-3312 (online)
dc.identifier.other 10.4103/wjnm.WJNM_117_18
dc.identifier.uri http://hdl.handle.net/2263/76135
dc.language.iso en en_ZA
dc.publisher Medknow Publications en_ZA
dc.rights © 2019 World Journal of Nuclear Medicine. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License. en_ZA
dc.subject Cancer en_ZA
dc.subject World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) en_ZA
dc.subject Radioiodine therapy en_ZA
dc.subject Thyroid carcinoma en_ZA
dc.title The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record